Drug Shortage Report for VIOKACE

Last updated on 2019-06-01 History
Report ID 73800
Drug Identification Number 02241933
Brand name VIOKACE
Common or Proper name VIOKACE 20880
Company Name APTALIS PHARMA CANADA ULC
Active Ingredient(s) AMYLASE PROTEASE LIPASE
Strength(s) 113400UNIT 112500UNIT 20880UNIT
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's count bottle
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-03-08
Actual start date 2019-03-05
Estimated end date 2019-06-21
Actual end date 2019-05-31
Shortage status Resolved
Updated date 2019-06-01
Company comments Delay with Viokase 20880 (SKU 20494) product release and raw material replenishment. Viokace 10440 (SKU 20495) remains available to alleviate impact.
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2019-06-01 English Compare
v15 2019-05-31 French Compare
v14 2019-05-31 English Compare
v13 2019-05-22 French Compare
v12 2019-05-22 English Compare
v11 2019-04-25 French Compare
v10 2019-04-25 English Compare
v9 2019-03-06 English Compare
v8 2019-03-05 French Compare
v7 2019-03-05 English Compare
v6 2019-02-08 French Compare
v5 2019-02-08 English Compare
v4 2019-02-07 French Compare
v3 2019-02-07 English Compare
v2 2019-01-29 French Compare
v1 2019-01-29 English Compare